Literature DB >> 23137536

MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting α subunit of protein kinase CKII in human colorectal cancer cells.

Soo Young Kim1, Young-Hoon Lee, Young-Seuk Bae.   

Abstract

We previously demonstrated that downregulation of protein kinase CKII induces cellular senescence in human colon cancer HCT116 cells. To investigate the role of microRNAs (miRNAs) in CKII downregulation during senescence, we employed computational algorithms. Four miRNAs (miR-186, miR-216b, miR-337-3p, and miR-760) were predicted to be miRNAs against CKIIα mRNA. Mimics of all four miRNAs jointly downregulated CKIIα expression in HCT116 cells. Reporter analysis and RT-PCR have suggested that these four miRNAs may stimulate degradation of CKIIα mRNA by targeting its 3' untranslated regions (UTRs). The four miRNA mimics increased senescent-associated β-galactosidase (SA-β-gal) staining, p53 and p21(Cip1/WAF1) expression, and reactive oxygen species (ROS) production. In contrast, concomitant knockdown of the four miRNAs by antisense inhibitors increased the CKIIα protein level and suppressed CKII inhibition-mediated senescence. Finally, CKIIα overexpression antagonized senescence induced by the four miRNA mimics. Therefore, the present results show that miR-186, miR-216b, miR-337-3p, and miR-760 cooperatively promote cellular senescence through the p53-p21(Cip1/WAF1) pathway by CKII downregulation-mediated ROS production in HCT116 cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23137536     DOI: 10.1016/j.bbrc.2012.10.117

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  50 in total

1.  miR-337-3p suppresses the proliferation and invasion of hepatocellular carcinoma cells through targeting JAK2.

Authors:  Xue-Liang Zuo; Zhi-Qiang Chen; Jun-Feng Wang; Jin-Guo Wang; Lin-Hu Liang; Juan Cai
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

Review 2.  MicroRNAs in colorectal cancer as markers and targets: Recent advances.

Authors:  Jing-Jia Ye; Jiang Cao
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection.

Authors:  Er-Lei Zhang; Jin Gu; Zun-Yi Zhang; Ke-Shuai Dong; Bin-Yong Liang; Zhi-Yong Huang
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

4.  Colorectal cancer cells are resistant to anti-EGFR monoclonal antibody through adapted autophagy.

Authors:  Zhi Chen; Shuohui Gao; Dayv Wang; Defeng Song; Ye Feng
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

5.  miR-337 can be a key negative regulator in melanoma.

Authors:  Wanan Xiao; Enyang Yao; Wei Zheng; Feng Tian; Lijie Tian
Journal:  Cancer Biol Ther       Date:  2017-05-12       Impact factor: 4.742

6.  miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3.

Authors:  Xing Hua; Yu Xiao; Wenhai Pan; Meiyun Li; Xiaoxiao Huang; Zexiao Liao; Qi Xian; Lina Yu
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

7.  Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel.

Authors:  Kan Chen; Wenjun Shi
Journal:  Tumour Biol       Date:  2016-02-08

8.  Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells.

Authors:  Chang Liu; Jinghua Wang; Yang Hu; Hong Xie; Min Liu; Hua Tang
Journal:  Chin J Cancer Res       Date:  2017-02       Impact factor: 5.087

9.  MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.

Authors:  Y Liu; Z Niu; X Lin; Y Tian
Journal:  Cancer Gene Ther       Date:  2017-03-10       Impact factor: 5.987

Review 10.  Noncoding RNA control of cellular senescence.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-09-01       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.